We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App

Thermo Fisher Presents Latest Solutions in Laboratory Equipment and Technology

By LabMedica International staff writers
Posted on 24 May 2023
Print article
Image: Thermo Scientific B•R•A•H•M•S KRYPTOR compact PLUS fully automated random-access benchtop immunanalyzer (Photo courtesy of Thermo Fisher Scientific)
Image: Thermo Scientific B•R•A•H•M•S KRYPTOR compact PLUS fully automated random-access benchtop immunanalyzer (Photo courtesy of Thermo Fisher Scientific)

Thermo Fisher Scientific (Waltham, MA, USA) is providing the latest updates in its equipment and technology to meet the needs of every size laboratory at the 2023 EuroMedLab Congress.

Among its latest equipment being featured at the industry event is the Thermo Scientific B·R·A·H·M·S KRYPTOR compact PLUS fully automated, random-access benchtop immunanalyzer that delivers remarkable precision, thereby improving patient outcomes. It is perfectly suited for small routine labs or research labs requiring up to 8 different immunoassays with a throughput of about 60 tests per hour. Its compact size and smart design make the Thermo Scientific B•R•A•H•M•S KRYPTOR compact PLUS an exceptional addition to clinical laboratories.

Thermo Fisher is also displaying the Thermo Scientific Indiko, a fully automated benchtop analyzer for clinical chemistry and specialty testing. This device offers genuine walk-away time for the operator once it's loaded. The Thermo Scientific Indiko clinical chemistry analyzer enhances patient care quality by providing quick results through sample-oriented testing. Also on display at the industry event is the Thermo Scientific TSQ Altis triple quadrupole mass spectrometer, which delivers unparalleled accuracy and precision for low-level compound detection and quantitation in complex matrices.

Visitors to the Thermo Fisher booth at EuroMedLab 2023 can experience the Thermo Scientific MAS Quality Controls and immunoassay reagents used in clinical chemistry, drug screening, diabetes management, and therapeutic drug monitoring. In addition to these, Thermo Fisher is also presenting the Thermo Scientific VeriSpray PaperSpray ion source, a high-throughput direct sampling solution, and the Thermo Scientific Vanquish Flex Binary UHPLC System, a flexible, biocompatible UHPLC system equipped with a binary pump.

Related Links:
Thermo Fisher Scientific

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more


view channel
Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

When dermatologists spot an unusual mark on a patient's skin, they face a choice: monitor it for some time or remove it for biopsy. Similarly, when removing breast tumors, surgeons must send excised tissues... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.